No Prescription |
 |
 | ||
|
PHENERGAN Promacot |
|
| ||
No Prescription » Prescription Drugs 13 » PHENERGAN Promacot Promethazine is used to relieve the symptoms of allergic reactions such as allergic rhinitis (runny nose and watery eyes caused by allergy to pollen mold or dust) allergic conjunctivitis (red watery eyes caused by allergies) allergic skin reactions and allergic reactions to blood or plasma products. Promethazine is used with other medications to treat anaphylaxis (sudden severe allergic reactions) and the symptoms of the common cold such as sneezing cough and runny nose. Promethazine is also used to relax and sedate patients before and after surgery during labor and at other times. Promethazine is also used to prevent and control nausea and vomiting that may occur after surgery and with other medications to help relieve pain after surgery. Promethazine is also used to prevent and treat motion sickness. Promethazine helps control symptoms but will not treat the cause of the symptoms or speed recovery. Promethazine is in a class of medications called phenothiazines. It works by blocking the action of a certain natural substance in the body.Promethazine comes as a tablet and syrup (liquid) to take by mouth and as a suppository to use rectally.When promethazine is used to treat allergies it is usually taken one to four times daily before meals and/or at bedtime. When promethazine is used to relieve cold symptoms it is usually taken every 4-6 hours as needed. When promethazine is used to treat motion sickness it is taken 30-60 minutes before travel and again after 8-12 hours if needed. On longer trips promethazine is usually taken in the morning and before the evening meal on each day of travel. When promethazine is used to treat or prevent nausea and vomiting it is usually taken every 4-6 hours as needed. Promethazine may also be taken at bedtime the night before surgery to relieve anxiety and produce quiet sleep. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take promethazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Promethazine suppositories are for rectal use only. Do not try to swallow the suppositories or insert in any other part of your body. Buy PHENERGAN Promacot and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About PHENERGAN Promacot: Product Type: Prescription Drugs 13 PHENERGAN ( Promacot Promethegan Generic Promethazine ) PHENERGAN (Promacot Promethegan Generic Promethazine) Promacot Promethegan Generic Promethazine 10mg Tabs Promacot Promethegan Generic Promethazine PHENERGAN
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
